Copertura documentale

Il Quality Gate pubblico registra 37 supporti documentali, 4 fonti indipendenti e 8 relazioni. Questi valori misurano documentazione e provenienza, non efficacia o appropriatezza clinica.

Documenti indicizzati collegati

• BRCA2 C-terminal clamp restructures RAD51 dimers to bind B-DNA for replication fork stability — Europe PMC
• Patient Experiences After Risk-Reducing Mastectomy Among Women Carrying BRCA1/2 Pathogenic Variants Without a Diagnosis of Breast Cancer — ClinicalTrials.gov
• Частота экспрессии гормональных рецепторов и мутаций BRCA1/2 у пациенток с раком молочной железы в Азербайджане — Crossref
• Clinically actionable genomic alterations in breast cancer brain metastases. — Europe PMC
• Reclassification of BRCA2 Variants of Uncertain Significance Using Saturation Genome Editing Combined with Clinical Phenotypes in Breast Cancer — Crossref
• Bilateral Risk-Reducing Mastectomy with Immediate Prosthetic Reconstruction in a Brca2 Mutation Carrier with Previous Breast Cancer: a Case Report and Review of the Literature — Crossref
• Comprehensive Genomic Profiling Reveals the Mutational Spectrum and Clinical Significance of BRCA1/2 and Other Cancer-Susceptibility Genes in Breast Cancer Patients from Southern Tunisia — Crossref
• Tyrer-Cuzick Lifetime Risk Is Not Associated With Non-BRCA1/2 Pathogenic Variants for Breast Carcinoma. — PubMed / NCBI
• Tyrer-Cuzick Lifetime Risk Is Not Associated With Non-BRCA1/2 Pathogenic Variants for Breast Carcinoma. — Europe PMC
• Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies — ClinicalTrials.gov
• Impact of BRCA2 pathogenic variants on outcomes to first-line CDK4/6 inhibitors plus endocrine therapy in HR-positive/HER2-negative metastatic breast cancer — Crossref
• Sustained benefit of adjuvant olaparib in women with germline BRCA1- and BRCA2- -associated high-risk HER2-negative early breast cancer: Updated results from the OlympiA phase III trial — Crossref

Collegamenti nel Knowledge Graph

• NM_000059.4(BRCA2):c.630A>T (p.Ile210=) — involves gene
• NM_000059.4(BRCA2):c.4504C>T (p.Gln1502Ter) — involves gene
• NM_000059.4(BRCA2):c.2753dup (p.Asn918fs) — involves gene
• NM_000059.4(BRCA2):c.1629_1632del (p.His543fs) — involves gene
• NM_000059.4(BRCA2):c.7187T>G (p.Leu2396Trp) — involves gene
• NM_000059.4(BRCA2):c.3183_3184delinsTT (p.Lys1061_Pro1062delinsAsnSer) — involves gene
• NM_000059.4(BRCA2):c.2798_2799dup (p.Gly934fs) — involves gene
• NM_000059.4(BRCA2):c.323dup (p.Asn108fs) — involves gene
• GRCh38/hg38 13q13.1(chr13:32369782-32373167)x1 — involves gene
• NM_000059.4(BRCA2):c.4227A>G (p.Leu1409=) — involves gene

Come interpretare questa pagina

Una relazione documentale non equivale a una raccomandazione. Risultati favorevoli nelle condizioni studiate, non favorevoli nelle condizioni studiate, non concordanti o con dati insufficienti restano consultabili nel motore con la loro provenienza.

Privacy

Questa pagina deriva esclusivamente dal patrimonio scientifico pubblico indicizzato. Il Publisher non usa IP, cookie, account, cronologia, fingerprint o ricerche individuali.

Quality Gate documentale: 96/100 · ultimo aggiornamento Settembre 29, 2026